Felicia Marshall v. HHS - HPV, Guillain-Barré Syndrome (“GBS”) and chronic inflammatory demyelinating polyneuropathy (“CIDP”) (2017)

Felicia Marshall received the human papillomavirus (HPV) vaccine on June 21, 2011. She alleged that this vaccine caused her to develop Guillain-Barré Syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), with residual effects lasting more than six months.

Respondent denied that the HPV vaccine caused her alleged injuries. Despite the denial, the parties reached a stipulation to resolve the case.

The court adopted the stipulation and awarded Felicia Marshall compensation totaling $378,463.36. This amount included a lump sum of $162,098.63 for first-year life care expenses, pain and suffering, and past unreimbursable expenses.

Additionally, $156,364.73 was awarded to reimburse a Medicaid lien, payable jointly to Ms. Marshall and First Recovery Group, LLC.

A further amount was allocated for the purchase of an annuity contract. The decision was issued on June 1, 2017, following the filing of the stipulation on the same date.